Tuesday, 9 July 2019

Potential IPO candidate BioNTech secures $325 million in financing round

German biotech firm BioNTech has secured $325 million in a private financing round to boost its cancer immunotherapies pipeline, the company said on Tuesday.


No comments:

Post a Comment